BONUS Episode: Dr. Michael Greger on Diet, Heart Disease & Rethinking Stents
Podcast Episode · Heart Doc VIP with Dr. Joel Kahn · 07/18/2025 · 29m
Related Articles
Heart scarring linked to abnormal rhythms in older male endurance athletes
Scar tissue in the heart was associated with abnormal heart rhythms among healthy, long-time male endurance athletes age 50 or older, potentially increasing their risk…
Determinants of 15‐Year Progression‐Free Survival in Multiple Myeloma; Real‐World Data From a Single Institution
9% of patients with multiple myeloma achieve 15-year progression-free survival; Kaplan-Meier curves for PFS (A) and OS (B).
Thread by @DNIGabbard on Thread Reader App
@DNIGabbard: 🧵 Americans will finally learn the truth about how in 2016, intelligence was politicized and weaponized by the most powerful people in the Obama…
Chronic venous insufficiency linked to increased cardiovascular disease and mortality risk
In light of reports from the White House that President Donald J. Trump has been diagnosed with Chronic Venous Insufficiency (CVI), the American Heart Association…
Subscribe | Blood Cancers Today
Sign up for Blood Cancers Today eNewsletters to join an extensive community of hematologic oncology professionals and get the latest news and insights from the…
Prognostic Value of Microvascular Function in Takotsubo Syndrome: A Pooled Analysis of Individual Patient Data
AbstractBackgroundCoronary microvascular dysfunction appears to play a major role in the pathogenesis of Takotsubo syndrome (TTS). However, the prognostic value of microvascular function measured i…
Radiation + IO May Improve OS and RFS in Biliary Cancer | GI Oncology Now
The ACCORD trial evaluated the efficacy of combined IO and radiotherapy in patients with biliary cancers.
Valve Area Planimetry on 4D-CT for Significant Aortic Stenosis: Correlations With Echocardiography and Optimal Thresholds
View all available purchase options and get full access to this article. Otto C.M., Nishimura R.A., Bonow R.O., et al. 2020 ACC/AHA guideline for the…
Myeloma Drug’s Comeback Nixed by FDA Panel
Advisory committee says benefits of belantamab mafodotin don’t outweigh risks
Submission Details – ASCO
location_on Moscone West | San Francisco, CA & Online For information regarding abstract submission, including abstract categories, guidelines, and policies, please review the pages linked
